Affiliation:
1. IRCCS Istituto Ortopedico Galeazzi , Milan , Lombardia , Italy
2. Università Vita-Salute San Raffaele , Milan , Italy
Abstract
Abstract
The contribution of laboratory medicine in delivering value-based care depends on active cooperation and trust between pathologist and clinician. The effectiveness of medicine more in general depends in turn on active cooperation and trust between clinician and patient. From the second half of the 20th century, the art of medicine is challenged by the spread of artificial intelligence (AI) technologies, recently showing comparable performances to flesh-and-bone doctors in some diagnostic specialties. Being the principle source of data in medicine, the laboratory is a natural ground where AI technologies can disclose the best of their potential. In order to maximize the expected outcomes and minimize risks, it is crucial to define ethical requirements for data collection and interpretation by-design, clarify whether they are enhanced or challenged by specific uses of AI technologies, and preserve these data under rigorous but feasible norms. From 2018 onwards, the European Commission (EC) is making efforts to lay the foundations of sustainable AI development among European countries and partners, both from a cultural and a normative perspective. Alongside with the work of the EC, the United Kingdom provided worthy-considering complementary advice in order to put science and technology at the service of patients and doctors. In this paper we discuss the main ethical challenges associated with the use of AI technologies in pathology and laboratory medicine, and summarize the most pertaining key-points from the guidelines and frameworks before-mentioned.
Subject
Biochemistry (medical),Clinical Biochemistry,General Medicine
Reference40 articles.
1. Pennestrì, F, Banfi, G. Value-based healthcare: the role of laboratory medicine. Clin Chem Lab Med 2019;57:798–801. https://doi.org/10.1515/cclm-2018-1245.
2. Grmek, M. Western medical thought from antiquity to the middle ages. Cambridge, Massachussets: Harvard University Press; 1988.
3. Kluytmans, A, Tummers, M, van der Wilt, GJ, Grutters, J. Early assessment of proof-of-problem to guide health innovation. Value Health 2019;22:601–6. https://doi.org/10.1016/j.jval.2018.11.011.
4. Davini, O. Il prezzo della salute. Roma: Nutrimenti; 2013.
5. Organization for Economic Cooperation and Development. Health at a glance 2021: OECD indicators. Paris: OECD Publishing; 2021.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献